KHIDI USAAug 30, 20211 min read7/19 - 7/26 North America Healthcare Market Weekly Report<Weekly Report>[1]https://www.biopharmadive.com/news/pfizer-biontech-africa-vaccine-supply-deal/603702/[2] https://news.google.com/covid19/map?hl=en-US&mid=%2Fm%2F02j71&gl=US&ceid=US%3Aen https://www.worldometers.info/coronavirus/?utm_campaign=instagramcoach1? [3]https://covid.cdc.gov/covid-data-tracker/#vaccinations [4] https://www.wsj.com/articles/why-covid-19-vaccines-work-well-against-delta-variant-11626957000 [5] https://www.wsj.com/articles/u-s-advisory-panel-signals-preliminary-support-for-covid-19-vaccine-boosters-11626989587 [6]https://www.fiercehealthcare.com/tech/amazon-rolls-out-aws-for-health-as-cloud-services-for-healthcare-genomics-and-biopharma [7] https://www.healthcaredive.com/news/medtech-ma-expected-to-be-robust-in-second-half-after-2021-began-with-a-fl/603553/ [8] https://www.wsj.com/articles/perkinelmer-buying-antibodies-maker-biolegend-for-5-25-billion-11627305156 [9] https://www.fiercepharma.com/pharma/restrictions-lifted-fda-free-to-resume-inspections-and-whittle-its-backlog-u-s-at-least [10] https://www.wsj.com/articles/u-s-proposes-upping-penalty-for-hospitals-that-dont-publish-prices-11626725949 https://www.cms.gov/newsroom/press-releases/cms-proposes-rule-increase-price-transparency-access-care-safety-health-equity[11] https://www.fiercebiotech.com/biotech/astrazeneca-hands-off-rights-to-pneumonia-prevention-medicine-for-11m-upfront-but-keeps-a [12]https://www.fiercepharma.com/pharma/astrazeneca-closes-mega-39b-alexion-buyout-despite-antitrust-fears-making-a-splash-rare [13] https://www.fiercehealthcare.com/payer/pharma-pushes-back-congress-flirtation-delaying-rebate-rule-to-help-pay-for-infrastructure [14]https://www.hhs.gov/about/news/2021/07/26/hhs-announces-phase-two-hpv-vaccination-campaign-young-adults.html
<Weekly Report>[1]https://www.biopharmadive.com/news/pfizer-biontech-africa-vaccine-supply-deal/603702/[2] https://news.google.com/covid19/map?hl=en-US&mid=%2Fm%2F02j71&gl=US&ceid=US%3Aen https://www.worldometers.info/coronavirus/?utm_campaign=instagramcoach1? [3]https://covid.cdc.gov/covid-data-tracker/#vaccinations [4] https://www.wsj.com/articles/why-covid-19-vaccines-work-well-against-delta-variant-11626957000 [5] https://www.wsj.com/articles/u-s-advisory-panel-signals-preliminary-support-for-covid-19-vaccine-boosters-11626989587 [6]https://www.fiercehealthcare.com/tech/amazon-rolls-out-aws-for-health-as-cloud-services-for-healthcare-genomics-and-biopharma [7] https://www.healthcaredive.com/news/medtech-ma-expected-to-be-robust-in-second-half-after-2021-began-with-a-fl/603553/ [8] https://www.wsj.com/articles/perkinelmer-buying-antibodies-maker-biolegend-for-5-25-billion-11627305156 [9] https://www.fiercepharma.com/pharma/restrictions-lifted-fda-free-to-resume-inspections-and-whittle-its-backlog-u-s-at-least [10] https://www.wsj.com/articles/u-s-proposes-upping-penalty-for-hospitals-that-dont-publish-prices-11626725949 https://www.cms.gov/newsroom/press-releases/cms-proposes-rule-increase-price-transparency-access-care-safety-health-equity[11] https://www.fiercebiotech.com/biotech/astrazeneca-hands-off-rights-to-pneumonia-prevention-medicine-for-11m-upfront-but-keeps-a [12]https://www.fiercepharma.com/pharma/astrazeneca-closes-mega-39b-alexion-buyout-despite-antitrust-fears-making-a-splash-rare [13] https://www.fiercehealthcare.com/payer/pharma-pushes-back-congress-flirtation-delaying-rebate-rule-to-help-pay-for-infrastructure [14]https://www.hhs.gov/about/news/2021/07/26/hhs-announces-phase-two-hpv-vaccination-campaign-young-adults.html
Comments